|
C1ORF107 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.4326000385978E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.56581431049108E-12 |
| Normal-vs-Stage2 |
5.298800E-03 |
| Normal-vs-Stage3 |
3.399000E-03 |
| Normal-vs-Stage4 |
2.360300E-02 |
| Stage1-vs-Stage2 |
1.453650E-01 |
| Stage1-vs-Stage3 |
7.341900E-03 |
| Stage1-vs-Stage4 |
6.076000E-03 |
| Stage2-vs-Stage3 |
6.108800E-01 |
| Stage2-vs-Stage4 |
4.517000E-01 |
| Stage3-vs-Stage4 |
7.533000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.25590040776092E-10 |
| Normal-vs-AfricanAmerican |
5.210100E-02 |
| Normal-vs-Asian |
1.197230E-01 |
| Caucasian-vs-AfricanAmerican |
8.609700E-02 |
| Caucasian-vs-Asian |
7.812000E-01 |
| AfricanAmerican-vs-Asian |
2.990000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.50870000223702E-08 |
| Normal-vs-Female |
6.53310000542362E-08 |
| Male-vs-Female |
5.179400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.294300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.48649999479156E-08 |
| Normal-vs-Age(61-80Yrs) |
1.41989999979941E-07 |
| Normal-vs-Age(81-100Yrs) |
2.690000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.648400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.549000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.012000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.636800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.191000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.857600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.096230E-03 |
| Normal-vs-Grade 2 |
5.44486677966916E-12 |
| Normal-vs-Grade 3 |
2.05299999999076E-05 |
| Normal-vs-Grade 4 |
1.822000E-01 |
| Grade 1-vs-Grade 2 |
2.535800E-01 |
| Grade 1-vs-Grade 3 |
3.754400E-02 |
| Grade 1-vs-Grade 4 |
1.278190E-02 |
| Grade 2-vs-Grade 3 |
8.121400E-03 |
| Grade 2-vs-Grade 4 |
5.355400E-04 |
| Grade 3-vs-Grade 4 |
1.063980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62503344114384E-12 |
| Normal-vs-ccB subtype |
1.823850E-03 |
| ccA subtype-vs-ccB subtype |
1.92085999999314E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.3172999997807E-07 |
| Normal-vs-N1 |
2.488400E-01 |
| N0-vs-N1 |
9.707800E-01 |
|
|
